{"nctId":"NCT05391555","briefTitle":"Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age","startDateStruct":{"date":"2022-10-01","type":"ACTUAL"},"conditions":["Opioid Toxicity","Pupillary Miosis","Respiratory Depression"],"count":10,"armGroups":[{"label":"Remifentanil Infusion and Recovery","type":"EXPERIMENTAL","interventionNames":["Drug: Remifentanil Hydrochloride","Device: Pupillometry measurement"]}],"interventions":[{"name":"Remifentanil Hydrochloride","otherNames":[]},{"name":"Pupillometry measurement","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy, BMI \\< 35 kg/m2\n\nExclusion Criteria:\n\n* current or recent opioid use\n* opioid or other substance use disorder\n* known or suspected OSA or sleep disordered breathing\n* ischemic heart disease, heart failure or symptomatic arrhythmia history\n* ocular disease or previous eye surgery\n* active use of alpha adrenergic blockers, anticholinergic medications,\n* active use of antidepressant or mood stabilizing medications\n* active use of phosphodiesterase inhibitors\n* use of stimulant or appetite suppressant medications\n* active use of antihypertensive or antiarrhythmic medications\n* use of topical eye medications.","healthyVolunteers":true,"sex":"ALL","minimumAge":"40 Years","maximumAge":"60 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Area Under the Time Concentration Curve (AUROC )","description":"PUAL measured by pupillometer. PUAL at zero-moderate opioid concentration (\\<1.8 ng/mL) versus high-toxic opioid concentration (\\>2.5 ng/mL) were dichotomous classifiers.\n\nReceiver Operating Characteristic curve constructed, with AUROC reported","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.9700","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":[]}}}